Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Acknowledgements
- Haloarcula marismortui is not a human pathogen
- Antibiotic - first definition
- Antibiotic - a broader definition
- Penicillin
- Paradox
- Antibiotic specificity problems
- Differences between ribosomes sensitivity
- Good news
- Bad news
- A complete 70S ribosome
- Large subuint
- A fifth active site at the large ribosimal subunit
- Structures of anti-ribosomal antibiotics
- Binding of puromycin in the large subunit
- Binding of anisomycin in the large subunit
- Binding of sparsomycin in the large subunit
- Binding of blasticidin in the large subunit
- Binding of tylosin in the large subunit
- Large/small subunit antibiotics
- Anisomycin binding to the A cleft
- Anisomycin cause conformation change
- Position of U2539
- Macrolide antibiotics
- Ribosome-antibiotic complexes
- Resistance to macrolide antibiotic
- Position 2099 identity is significant
- Azithromycin
- Differences in peptide length product
- Textbook explanation
Topics Covered
- Introduction to a paradox: how can a universally conserved cellular component be a target for pharmacologically useful antibiotics?
- Introduction to ribosome structure
- Antibiotic binding sites cluster in the ribosome
- The source of the species specificity of antibiotics that interact with the A-site cleft
- How macrolides interact with the ribosome
- The structural consequences of mutations that make ribosomes resistant to macrolides
- The toxicity of macrolides is not well understood
- 13-deoxytedanolide, a novel macrolide with novel species specificity that binds to a novel site in the ribosome
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Moore, P. (2008, May 15). The interaction of antibiotics with the large ribosomal subunit from Haloarcula marismortui [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 26, 2024, from https://doi.org/10.69645/SEQG5769.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Peter Moore has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
The interaction of antibiotics with the large ribosomal subunit from Haloarcula marismortui
A selection of talks on Biochemistry
Hide